USFDA investigates death of another infant given Abbott formula: Bloomberg

The FDA also inspected the facility in February and March and found unsanitary conditions that led the plant to shut down until Abbott could fix the problems.

Published On 2022-06-23 05:30 GMT   |   Update On 2022-06-23 05:30 GMT
Advertisement

New Delhi: U.S. Food and Drug Administration officials are investigating the death of another infant who was given formula made by Abbott Laboratories.

The infant died in January and the FDA was notified June 10, according to a statement Wednesday.

"The investigation of this most recent consumer complaint is in its preliminary stages and the agency will provide an update as it learns more," the FDA said.

Advertisement

Abbott shares shed some gains on the news and were up 1.2% at 3:36 p.m. in New York.

Abbott recalled formula, including widely used Similac, in February after four babies became ill after consuming products made at the company's plant in Sturgis, Mich. Two of the infants died.

Read also: Abbott to release some nutrition products halted after baby formula recall

The FDA said it hasn't been able to definitively determine whether Abbott's formula was the reason for the illnesses or deaths. Abbott has said there is no conclusive evidence to link its formula to the illnesses or deaths.

The FDA also inspected the facility in February and March and found unsanitary conditions that led the plant to shut down until Abbott could fix the problems. The plant reopened earlier this month only to be beset by flood waters that halted its infant formula production last week.

Read also: Abbott labs India unit concludes recall of baby formula products manufactured at Michigan facility

Tags:    
Article Source : Bloomberg

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News